Browsing Category
Medicines for Cancer
11 posts
Oncology Medications Struggle in Brazil’s Public Health System: Funding Gaps and Access Challenges
The health strategist institute, portal & consultingfor workforce health & economic prosperity Joaquim Cardoso MSc. Servant Leader, Chief Research…
Desafios no Acesso a Medicamentos Oncológicos no SUS: Lacunas de Financiamento e Dificuldades de Acesso
The health strategist institute, portal & consultingfor workforce health & economic prosperity Joaquim Cardoso MSc. Servant Leader, Chief Research…
Unexpected Results: Vaccination Improves Effectiveness of Cancer Treatment — [9 % patients achieved complete remission, and 32% partial remission, in nasopharyngeal cancer]
health transformation institute (HTI) the most comprehensive knowledge portal for health transformation Joaquim Cardoso MSc*Founder and Chief Researcher…
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
Site Editor: Joaquim Cardoso MSc.Health Transformation — Institute for research, strategy and advisory Springer LinkCancer and Metastasis ReviewsMarek Z. Wojtukiewicz,…
A Cancer Trial’s Unexpected Result: Remission in Every Patient
The study was small, and experts say it needs to be replicated. But for 18 people with colorectal…
Global Oncology Trends 2022 — Outlook to 2026 [executive summary]
Oncologists report caseloads are 20–29% below pre-COVID-19 levels, and while cancer screenings in the U.S. have returned to…
Expanding Horizons for Treatment of Early-Stage Lung Cancer
NEJMChristine M. Lovly, M.D., Ph.D.May 25, 2022N Engl J Med 2022; Lung cancer remains the leading cause of…
New injectable immunotherapy treatment for rare form of triple negative breast cancer recommended by NICE
An estimated 100 people per year with triple negative breast cancer that has spread to other parts of…
A golden era of cancer clinical trials
Cancer immunotherapy is generating huge excitement, but the future may lie elsewhere, in antibody–drug conjugates, proteolysis-targeting chimeras, and…
Breast cancer: precision drugs make inroads against stubborn tumours
Financial TimesApril 7, 2022 Breast cancer has acquired a grim new status. It has overtaken lung cancer to…
